May 2013

Publication

The magnitude of any metabolic drug-drug interactions (DDIs) depends on fractional importance of inhibited pathway…

Danielle Pillsbury2013 年 5 月 30 日

Publication

Despite pharma's recent sea change in approach to drug discovery and development, U.S. pharmaceutical sciences…

Danielle Pillsbury2013 年 5 月 13 日

Publication

To evaluate the role of Fc receptors (FcR) on IgG distribution to the brain, the disposition of 8C2, a murine…

Danielle Pillsbury2013 年 5 月 6 日

Publication

The objective of this study was to evaluate qualitative and quantitative biodistribution of epidermal growth…

Danielle Pillsbury2013 年 5 月 6 日

Publication

Molecular targeting of cellular signaling pathways is a promising approach in cancer therapy, but often…

Danielle Pillsbury2013 年 5 月 1 日

Publication

Everolimus is a mammalian target of rapamycin (mTOR) inhibitor approved as an immunosuppressant and for…

Danielle Pillsbury2013 年 5 月 1 日

Publication

L-lactate represents a potential treatment for GHB overdose by inhibiting GHB renal reabsorption mediated by…

Danielle Pillsbury2013 年 5 月 1 日

Publication

Many drug–drug interactions (DDIs) in the pediatric population are managed based on data generated in…

Danielle Pillsbury2013 年 5 月 1 日

沪ICP备2022021526号